Search

everythinglearnresearchcommunity

for

Search:↓

Dutasteride, fesoterodine, and finasteride are beneficial for older patients, while most other drugs should be used cautiously or avoided.

Tofacitinib is safe and effective for treating moderate-to-severe alopecia areata.

Using existing drugs for new purposes could be a cost-effective way to treat chest pain and non-clogged heart arteries, with some drugs for lung blood pressure showing promise but needing more testing.

Minoxidil effectively lowers severe high blood pressure long-term but isn't for routine use.

Olanzapine reduces stress-related anxiety in rats when given acutely.

Oral tofacitinib may be an effective and tolerable treatment for some people with severe alopecia areata.

Baricitinib effectively treats alopecia areata, with over half of patients improving after 52 weeks.

Certain medications can reduce mortality risk in COPD patients, but others can increase risks of cardiovascular issues, postoperative delirium, and other adverse effects.

Tofacitinib works well for treating alopecia areata, especially when combined with corticosteroids, but is less effective if the disease has lasted over 2 years.

PAD is common but often missed, needing lifestyle changes and medication for better outcomes.

Low-dose oral minoxidil doesn't affect blood pressure in patients taking blood pressure meds.

Simvastatin/ezetimibe did not effectively treat severe alopecia areata and caused side effects in some patients.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

A medicine company has recalled a drug because it contained an unlisted blood pressure medication.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

The doxazosin plus tamsulosin combination improved symptoms effectively with fewer side effects.

Higher ACE2 levels in certain tissues may worsen COVID-19 in people with other health issues, especially older adults.

Olumiant should be covered for severe alopecia areata if certain conditions are met.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

Betamethasone is more effective long-term for alopecia areata than hydroxychloroquine.

Corticosteroid pulse therapy is more effective for severe alopecia areata than combination therapy.

Baricitinib was more effective than a placebo in regrowing hair in adults with alopecia areata after 36 weeks.

Some medications and supplements can cause serious side effects, including hair loss, heart rhythm problems, liver injury, and other health issues.

Temperaturas de 4 °C son ideales para conservar injertos capilares.

AH-001 could be a safer and more effective treatment for hair loss.

Certain compounds, especially those with a propionic substituent, could potentially be new treatments for hair loss and similar disorders.